Skip to content

Clinical trials

Migraine Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Country / region: Germany Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20064
20073
20084
20094
20112
20121
20132
20154
20162
20173
20181
201910
20206
20215
20224
20234
20247
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Terminated6
Unknown status4
Active, not recruiting4
Recruiting3
Suspended2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
AbbVie5
Amgen5
Universitätsklinikum Hamburg-Eppendorf4
Allergan3
H. Lundbeck A/S3
Novartis Pharmaceuticals3
Pfizer3
Teva Branded Pharmaceutical Products R&D, Inc.3
Universität Duisburg-Essen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders70
Headache21
Epilepsy2
Foramen Ovale, Patent2
Ischemic Attack, Transient2
Recurrence2
Stroke2
Asthma1
Dermatitis, Atopic1
Dizziness1

Trials

Showing 51 to 70 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.